BioMarin Pharmaceutical Inc marks Rare Disease Day with sculpture commission
BioMarin Pharmaceutical Inc is to commission a sculpture for its site in Shanbally, Cork, to signify the company’s commitment to supporting rare disease patients.
The theme for the commission, which is being held in association with the National Sculpture Factory, is a Tree of Life.
This follows in the footsteps of an installation at BioMarin’s US headquarters.
In the run up to Rare Disease Day 2020, submissions for the new sculpture from a number of artists across Ireland were reviewed by a panel of judges, including leading patient advocate, Avril Daly, Vice-President of EURORDIS, former Chairperson of Rare Diseases Ireland, and CEO of Retina International.
BioMarin’s mission of developing new treatments that will make a big impact on small patient populations is a shared purpose that has a deep effect on the workforce.
The team in Shanbally is commissioning the sculpture to capture the strong empathy which BioMarin’s employees in Ireland feel for rare disease patients and their families, and the company’s ambition to develop therapies that will help patients in the management of these challenging conditions.
“For more than two decades, we have been pioneering breakthrough treatments for patients suffering from rare genetic diseases,” said Mike O’Donnell, VP of Operations, BioMarin International Limited and Site Lead at Shanbally.
“Here in Cork we have an exceptional pool of life sciences talent and expertise. The Tree of Life initiative will represent our partnership with the rare disease community and be a daily reminder of our commitment to do everything we can to make a big impact on small patient populations.”
BioMarin is to announce the successful artist this summer, with the unveiling of the sculpture in autumn 2020.